Crohn’s disease patient-derived intestinal organoids were characterized by differentiation gene markers and then exposed to TNF-α, IFN-γ, IL-1β or LPS, or IL-28A with or without GLPG0634.
[American Journal of Physiology-Gastrointestinal and Liver Physiology]
6445218
{6445218:DPCMQNDI}
apa
50
1
159189
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-7f9787679cbe5dddc709d266ea025bbc%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22DPCMQNDI%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Xu%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-17%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EXu%2C%20P.%2C%20Becker%2C%20H.%2C%20Elizalde%2C%20M.%2C%20Pierik%2C%20M.%2C%20Masclee%2C%20A.%20A.%20M.%2C%20%26amp%3B%20Jonkers%2C%20D.%20M.%20A.%20E.%20%282021%29.%20Interleukin-28A%20Induces%20Epithelial%20Barrier%20Dysfunction%20in%20CD%20Patient-derived%20Intestinal%20Organoids.%20%3Ci%3EAmerican%20Journal%20of%20Physiology-Gastrointestinal%20and%20Liver%20Physiology%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1152%5C%2Fajpgi.00064.2020%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1152%5C%2Fajpgi.00064.2020%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DDPCMQNDI%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Interleukin-28A%20Induces%20Epithelial%20Barrier%20Dysfunction%20in%20CD%20Patient-derived%20Intestinal%20Organoids%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pan%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heike%22%2C%22lastName%22%3A%22Becker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Montserrat%22%2C%22lastName%22%3A%22Elizalde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marieke%22%2C%22lastName%22%3A%22Pierik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ad%20A.M.%22%2C%22lastName%22%3A%22Masclee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20M.A.E.%22%2C%22lastName%22%3A%22Jonkers%22%7D%5D%2C%22abstractNote%22%3A%22Intestinal%20barrier%20dysfunction%20is%20a%20pathogenic%20hallmark%20in%20Crohn%27s%20disease%20%28CD%29.%20Identifying%20key%20players%20that%20regulate%20intestinal%20barrier%20may%20provide%20novel%20leads%20for%20therapeutic%20intervention.%20Interleukin-28A%20%28IL-28A%29%20is%20a%20newly%20identified%20IL-10%5C%2Finterferon%20cytokine%20family%20member%2C%20with%20its%20most%20implicated%20function%20being%20antiviral%20and%20anti-proliferative%20properties.%20However%2C%20the%20role%20and%20underlying%20mechanisms%20of%20IL-28A%20in%20the%20regulation%20of%20epithelial%20barrier%20in%20CD%20remain%20so%20far%20unexplored.%20IL-28A%20levels%20were%20measured%20in%20the%20plasma%20and%20biopsies%20of%20CD%20patients%20and%20healthy%20subjects.%20CD%20patient-derived%20intestinal%20organoids%20were%20characterized%20by%20differentiation%20gene%20markers%20and%20then%20exposed%20to%20TNF-%5Cu03b1%2C%20IFN-%5Cu03b3%2C%20IL-1%5Cu03b2%20or%20LPS%2C%20or%20IL-28A%20with%20or%20without%20GLPG0634%20%28filgotinib%29.%20Epithelial%20permeability%20was%20assessed%20by%20FITC-D4%20flux.%20Expression%20of%20junctional%20components%20was%20analyzed%20by%20qRT-PCR%2C%20immunofluorescence%20staining%20or%20western%20blotting.%20JAK-STAT%20activity%20was%20analyzed%20by%20western%20blotting.%20IL-28A%20levels%20were%20increased%20in%20the%20plasma%20and%20biopsies%20from%20active%20CD%20patients%20as%20compared%20to%20healthy%20subjects.%20IL-28A%20and%20its%20receptor%20complex%20IL-28AR%5C%2FIL-10R2%20were%20detected%20in%20CD%20patient-derived%20intestinal%20organoids%20and%20showed%20a%20selective%20response%20to%20IFN-%5Cu03b3%20exposure.%20IL-28A%20triggered%20epithelial%20barrier%20disruption%2C%20accompanied%20by%20reduced%20ZO-1%20and%20E-Cadherin%20expression.%20This%20effect%20was%20mediated%20by%20JAK-STAT1%20pathway.%20Pre-incubation%20with%20the%20JAK1%20inhibitor%20filgotinib%20ameliorated%20the%20barrier%20dysfunction%20induced%20by%20IL-28A.%20These%20results%20identified%20IL-28A%20as%20a%20novel%20regulator%20of%20epithelial%20barrier%20function%20and%20could%20be%20a%20putative%20target%20for%20CD%20treatment.%20We%20provide%20novel%20basic%20evidence%20that%20restoring%20intestinal%20barrier%20is%20a%20potential%20mechanism%20that%20contributes%20to%20the%20clinical%20benefits%20of%20JAK1%20inhibitor%20in%20CD%20patients.%22%2C%22date%22%3A%22February%2017%2C%202021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1152%5C%2Fajpgi.00064.2020%22%2C%22ISSN%22%3A%220193-1857%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.physiology.org%5C%2Fdoi%5C%2Fabs%5C%2F10.1152%5C%2Fajpgi.00064.2020%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-02-18T01%3A28%3A17Z%22%7D%7D%5D%7D
Xu, P., Becker, H., Elizalde, M., Pierik, M., Masclee, A. A. M., & Jonkers, D. M. A. E. (2021). Interleukin-28A Induces Epithelial Barrier Dysfunction in CD Patient-derived Intestinal Organoids. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00064.2020 Cite
